Evidence map›Paper›PMID 38918503›Full record

ArticleScientific reports2024

Hodgkin lymphoma: hypodense lesions in mediastinal masses.

Adrian Damek, Lars Kurch, Friedrich Christian Franke, Andishe Attarbaschi, Auke Beishuizen, Michaela Cepelova, Francesco Ceppi, Stephen Daw, Karin Dieckmann, Ana Fernández-Teijeiro and 21 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Adrian DamekDepartment of Radiology, University Hospital Halle/Saale, Ernst-Grube-Strasse 40, 06120, Halle/Saale, Germany.
Lars KurchDepartment of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
Friedrich Christian FrankeDepartment of Radiology, University Hospital Halle/Saale, Ernst-Grube-Strasse 40, 06120, Halle/Saale, Germany.
Andishe AttarbaschiDepartment of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
Auke BeishuizenErasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Michaela CepelovaDepartment of Pediatric Hematology and Oncology, University Hospital Motol and Second Medical Faculty of Charles University, Prague, Czech Republic.
Francesco CeppiDivision of Pediatrics, Department of Woman-Mother-Child, Pediatric Hematology-Oncology Unit, University Hospital of Lausanne, Lausanne, Switzerland.
Stephen DawDepartment of Pediatric Hematology and Oncology, University College London Hospitals, London, UK.
Karin DieckmannDepartment of Radiation Oncology, University Hospital Vienna, Vienna, Austria.
Ana Fernández-TeijeiroPediatric Onco-Hematology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Tobias FeuchtingerPediatric Hematology, Oncology and Stem Cell Transplantation, Dr. Von Hauner University Children's Hospital Ludwig-Maximilians-University, Munich, Germany.
Jamie E FlerlageDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Alexander FossåDepartment of Medical Oncology and Radiotherapy, Oslo University Hospital, Oslo, Norway.
Thomas W GeorgiDepartment of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
Dirk HasencleverInstitute of Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
Andrea HraskovaDepartment of Pediatric Hematology and Oncology, University Children's Hospital, Bratislava, Slovakia.
Jonas KarlenKarolinska University Hospital, Astrid Lindgrens Childrens Hospital, Stockholm, Sweden.
Tomasz KlekawkaInstitute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Regine KlugeDepartment of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
Dieter KörholzDepartment of Pediatric Hematology and Oncology, Justus-Liebig University, Gießen, Germany.
Judith Landman-ParkerHôpital Armand-Trousseau Sorbonne Universitè, Paris, France.
Thierry LeblancService d'Hématologie Pédiatrique, Hôpital Robert-Debré, Paris, France.
Christine Mauz-KörholzDepartment of Pediatric Hematology and Oncology, Justus-Liebig University, Gießen, Germany.
Markus MetzlerPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine, University Hospital, Erlangen, Germany.
Jane PearsDepartment of Pediatric Hematology and Oncology, Our Lady's Children's Hospital, Dublin, Ireland.
Jonas SteglichDepartment of Radiology, University Hospital Halle/Saale, Ernst-Grube-Strasse 40, 06120, Halle/Saale, Germany.
Anne UyttebroeckDepartment of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium.
Dirk VordermarkDepartment of Radiation Oncology, Medical Faculty of the Martin-Luther-University, Halle (Saale), Germany.
William Hamish WallaceDepartment of Paediatric Oncology, Royal Hospital for Sick Children, University of Edinburgh, Edinburgh, UK.
Walter Alexander WohlgemuthDepartment of Radiology, University Hospital Halle/Saale, Ernst-Grube-Strasse 40, 06120, Halle/Saale, Germany.
Dietrich StoevesandtDepartment of Radiology, University Hospital Halle/Saale, Ernst-Grube-Strasse 40, 06120, Halle/Saale, Germany. dietrich.stoevesandt@medizin.uni-halle.de.ORCID 0000-0001-5105-4488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypodense volumes (HDV) in mediastinal masses can be visualized in a computed tomography scan in Hodgkin lymphoma. We analyzed staging CT scans of 1178 patients with mediastinal involvement from the EuroNet-PHL-C1 trial and explored correlations of HDV with patient characteristics, mediastinal tumor volume and progression-free survival. HDV occurred in 350 of 1178 patients (29.7%), typically in larger mediastinal volumes. There were different patterns in appearance with single lesions found in 243 patients (69.4%), multiple lesions in 107 patients (30.6%). Well delineated lesions were found in 248 cases (70.1%), diffuse lesions were seen in 102 cases (29.1%). Clinically, B symptoms occurred more often in patients with HDV (47.7% compared to 35.0% without HDV (p = 0.039)) and patients with HDV tended to be in higher risk groups. Inadequate overall early-

Indexed as

Hodgkin DiseaseMediastinal NeoplasmsAdolescentAdultAgedFemaleFluorodeoxyglucose F18HumansMaleMediastinumMiddle AgedPositron-Emission TomographyProgression-Free SurvivalTomography, X-Ray ComputedYoung AdultFluorodeoxyglucose F18Hodgkin lymphomaHypodense lesionThymic cystTomographyX-ray computed

Identifiers

PMID38918503
PMCPMC11199705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.